NCT03525873 2026-04-15
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
Clinical Trials
11 trialsNCT06905587 2025-12-11
EMBRAIN
Odense University Hospital
Phase 3 Recruiting
NCT05041946 2022-09-29
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00031798 2021-09-09
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT03218254 2018-12-05
MICRO
Odense University Hospital
Phase 3 Unknown
NCT00516269 2018-01-03
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01773837 2017-05-09
Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients
Clinica Universidad de Navarra, Universidad de Navarra
Phase 3 Terminated
NCT00376675 2016-08-01
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01497548 2011-12-22
Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients
University of Malaya
Phase 3 Unknown
NCT00273741 2009-12-07
Ritaline
University Hospital, Grenoble
Phase 3 Terminated